Ritlecitinib demonstrates long-term improvements in regrowth of scalp hair, eyebrows, and eyelashes at 24 months in adults and adolescents with alopecia areata (AA) and ≥ 25% scalp hair loss. Of the ...

GPT-4o achieved ICC/CCC of 0.815/0.866 versus in-person SALT scoring and 0.833/0.817 versus image-based scoring, while expert ...

While the JAK inhibitor market for alopecia areata (AA) has grown increasingly crowded in recent years, Rinvoq’s clinical performance in the hair follicle-attacking autoimmune disease could earn ...

Please provide your email address to receive an email when new articles are posted on . MILAN — As treatment options for alopecia areata become available, images of scalp hair loss corresponding to a ...

PARIS — Long-term results from the ALLEGRO clinical trial program of Pfizer’s JAK inhibitor ritlecitinib for severe alopecia areata showed that complete scalp regrowth occurred in a good proportion of ...

If you have alopecia areata, your doctor may be able to estimate the level of hair loss simply by looking at your scalp. But they may also use a test called the Severity of Alopecia Tool, commonly ...

Upadacitinib demonstrated significant efficacy in promoting scalp hair regrowth in severe alopecia areata patients, achieving primary endpoints in nearly half of the participants. The phase 3 trials ...

Theres nothing you did to cause your hair to fall out. (Alopecia areata is, after all, an autoimmune disease.) But there are things you can do to retain your remaining hair, as well as speed up the ...

On the heels of Eli Lilly’s landmark approval last summer, Pfizer is stepping up to the plate in alopecia areata—and it’s coming equipped with an adolescent nod to put the pressure on Olumiant. Late ...

Alopecia areata affects millions of Americans regardless of age, race, or gender, manifesting as patchy hair loss across the scalp and sometimes other body areas. This autoimmune condition occurs when ...